These experts discuss the factors that incur increased risk for malignant endometrial polyps, the relationship between chronic endometritis and endometrial polyps, whether the
etonogestrel subdermal implant can treat EIN, and new endometrial ablation technology
Trata-se da oferta de dois dispositivos contraceptivos as mulheres entre 15 e 19 anos: o implante subdermico liberador de
etonogestrel, com duracao de tres anos, e o sistema intrauterino liberador de levonorgestrel, com duracao de cinco anos.
A study by Tocce et al (41) revealed that only 2.6% of adolescent mothers (n=4/153; Relative Risk=5.5; CI: 1.9 -12.7) with immediate postpartum
Etonogestrel implant insertion experienced a repeat pregnancy at 12 months versus 18.6% (38/204) of the control group adolescent females.
Use of effective forms of contraception --especially long-acting reversible forms of contraception (LARC), such as the IUD or the
etonogestrel rod--still remain low at the time of sexual debut.
for the development of an injectable
etonogestrel contraceptive with 6- and 12-month durations.
Bury, "Bleeding related to
etonogestrel subdermal implant in a US population," Contraception, vol.
Implanon NXT is a single rod system containing
etonogestrel 68 mg, and it is the only contraceptive implant available in the Western Cape public health sector.
Because estrogen increases vWF, treatment for von Willebrand syndrome should be progestin only, either oral pills, medroxyprogesterone acetate (MPA, or Depo-Provera injections), or an
etonogestrel implant.
Both the 5-year, two-rod levonorgestrel implant (Jadelle) and the 3-year, single-rod
etonogestrel implant (Implanon NXT) were registered with the SA Medicines Control Council for use, but only Implanon NXT was made available in public health clinics as part of the national contraception programme.
RR differed according to type of product: users of a patch (norgestrolmin) had an RR of 2.0 (95% CI, 1.76-2.18); users of a vaginal ring (
etonogestrel), 1.6 (95% CI, 1.55-1.69); users of a levonorgestrel intrauterine system, 1.4 (95% CI, 1.31-1.42); and users of progestogen-only pills had an RR of 1.34 (95% CI, 1.27-1.40).
The implant slowly releases
etonogestrel into the body over a three-year period.
(Acquisition routes of the
Etonogestrel liberator sub-dermal contraceptive implant in pacients from family planning consultation at the Hospital Materno Infantil "Dr.